What is chikungunya fever? Should I be worried about traveling with my family?
Chikungunya (chik-un-GUN-yuh) fever is an illness caused by a virus. It is spread by mosquitoes. The name means "bends you up" or "stooped walk" because the infection causes severe joint and muscle pain. If you plan to travel where chikungunya outbreaks regularly happen, get advice from your healthcare professional or a travel clinic before you go.
You can get a vaccine to protect against chikungunya, but no specific treatment is available.
Chikungunya rarely causes serious problems or death. Symptoms include sudden high fever, headache, fatigue, rash, nausea and red eyes. Symptoms of chikungunya often appear within 2 to 7 days after a bite from an infected mosquito. Many people get better within a couple of weeks. But others have joint and muscle pain that can last for months or years after they've been infected with the virus.
The goal of treatment for the infection is to relieve symptoms with rest, fluids and medicines, such as acetaminophen (Tylenol, others). Don't take aspirin, ibuprofen (Advil, Motrin IB, others) or naproxen sodium (Aleve) until infections with symptoms similar to those of chikungunya fever have been ruled out. For ongoing joint and muscle pain, drugs that ease rheumatoid arthritis may help. Ask your healthcare professional for advice.
Where is chikungunya found?
Once found only in Africa and Asia, the chikungunya virus has spread quickly since 2004. Now, more than one-third of people in the world live in places with risk factors for infection. These places include the Americas, Africa, Asia, Europe, and islands in the Caribbean and the Indian and Pacific oceans.
How is the chikungunya virus spread?
People get chikungunya when bitten by a mosquito infected with the virus. Chikungunya is not spread from person to person. But mosquitoes pick up the virus when biting an infected person. If you have the infection, avoid getting new mosquito bites to keep the virus from spreading to others. Avoid travel too.
How concerned should I be about chikungunya?
Many people get better with no other symptoms after 1 to 2 weeks. But others may have joint and muscle pain for months or even years. This is called chronic chikungunya arthritis. It affects at least 40% of those who become infected with the virus.
Death from chikungunya is rare. But the virus can cause severe problems in some people. People at higher risk include older adults, those with long-term conditions such as high blood pressure or diabetes, young children, and pregnant people who might spread the virus to their babies.
Complications can include severe conditions of the eyes, heart and nerves. People who have been infected once are likely to be protected from future infections.
How can I prevent chikungunya infection?
People who are at risk of getting chikungunya may choose to get a vaccine. Two vaccines are approved by the U.S. Food and Drug Administration.
- Ixchiq. This vaccine is made from weakened chikungunya virus. It causes mild infection that a healthy immune system can control. The vaccine can be used by people age 18 and older. But there may be a higher risk of serious side effects in people age 60 and older who take this vaccine. The vaccine gives protection with one dose.
- Vimkunya. This vaccine is made from pieces of the chikungunya virus. It can't cause chikungunya infection. The pieces of the virus allow the immune system to get ready to protect the body. This vaccine can be used by people age 12 and older. The vaccine gives protection with one dose.
If you're traveling to an area with known outbreaks of chikungunya, take care to prevent getting the infection. Because chikungunya isn't spread from human to human but by mosquitoes, preventing bites is your best protection. Follow these tips to prevent mosquito bites:
- Use an insect repellent that has DEET or picaridin. Check that it's registered by the U.S. Environmental Protection Agency.
- Wear long sleeves and pants.
- Remove standing water when possible.
- Protect yourself indoors with screens, air conditioning and mosquito netting.
If you're pregnant, especially late in your pregnancy, don't travel anywhere with a chikungunya outbreak. The virus can be passed on to your baby and cause serious complications.
If you're an older adult or have a condition such as diabetes or heart disease, you have an increased risk of severe disease. If possible, don't travel to areas with ongoing chikungunya outbreaks.
When should I see a healthcare professional?
Get medical care if you think you or a family member may have chikungunya. This is especially important if you have recently traveled to an area with an ongoing outbreak. Your healthcare professional may order blood tests to look for chikungunya or similar diseases. If you're sick with chikungunya, prevent new mosquito bites to keep the virus from spreading.
June 07, 2025
- Amaral JK, et al. Chronic chikungunya arthritis and rheumatoid arthritis: What they have in common. The American Journal of Medicine. 2020; doi:10.1016/j.amjmed.2019.10.005.
- Battisti, V, et al. Antivirals against the chikungunya virus. Viruses. 2021; doi:10.3390/v13071307.
- Chikungunya virus. Centers for Disease Control and Prevention. https://www.cdc.gov/chikungunya/. Accessed April 4, 2022.
- Chikungunya. World Health Organization. http://www.who.int/mediacentre/factsheets/fs327/en/#. Accessed April 4, 2022.
- AskMayoExpert. Chikungunya fever. Mayo Clinic; 2022.
- Wilson ME, et al. Chikungunya fever: Epidemiology, clinical manifestations, and diagnosis. https://www.uptodate.com/contents/search. Accessed April 4, 2022.
- Ixchiq. U.S. Food and Drug Administration. https://www.fda.gov/vaccines-blood-biologics/ixchiq. Accessed Nov. 18, 2023.
- Vimkunya. U.S. Food and Drug Administration. https://www.fda.gov/vaccines-blood-biologics/vimkunya. Accessed May 13, 2025.
- FDA and CDC recommend pause in use of Ixchiq (chikungunya vaccine, live) in individuals 60 years of age and older while postmarketing safety reports are investigated. U.S. Food and Drug Administration. https://www.fda.gov/vaccines-blood-biologics/safety-availability-biologics/fda-and-cdc-recommend-pause-use-ixchiq-chikungunya-vaccine-live-individuals-60-years-age-and-older. Accessed May 14, 2025.
- Medical review (expert opinion). Mayo Clinic. May 14, 2025.
See more Expert Answers